UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act Of 1934
Date of Report (Date of earliest event reported): May 8, 2023
Palatin Technologies, Inc. |
(Exact name of registrant as specified in its charter) |
Delaware |
| 001-15543 |
| 95-4078884 |
(State or other jurisdiction |
| (Commission |
| (IRS employer |
of incorporation) |
| File Number) |
| identification number) |
4B Cedar Brook Drive, Cranbury, NJ |
| 08512 |
(Address of principal executive offices) |
| (Zip Code) |
Registrant's telephone number, including area code: (609) 495-2200
Not Applicable
(Former name or former address, if changed since last report.)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
☐ | Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
☐ | Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
☐ | Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
☐ | Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Securities registered pursuant to Section 12(b) of the Act:
Title of Each Class |
| Trading Symbol(s) |
| Name of Each Exchange on Which Registered |
Common Stock |
| PTN |
| NYSE American |
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company ☐
If an emerging growth company, indicate by checkmark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Item 8.01 Other Events.
On May 8, 2023, Palatin Technologies, Inc. issued a press release announcing a replay of a key opinion leader webinar held on May 8, 2023 on PL9643 in treating signs and symptoms of moderate to severe dry eye disease. A copy of this press release is attached as Exhibit 99.1 and is incorporated herein by reference.
On May 9, 2023, Palatin Technologies, Inc. issued a press release announcing a presentation, on May 8, 2023, of a poster on PL8177 for ulcerative colitis at the Digestive Disease Week annual meeting in Chicago, Illinois. A copy of this press release is attached as Exhibit 99.2 and incorporated herein by reference.
Item 9.01 Financial Statements and Exhibits.
(d) Exhibits:
| ||
|
2 |
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
| PALATIN TECHNOLOGIES, INC. |
| |
|
|
|
|
Date: May 9, 2023 | By: | /s/ Stephen T. Wills |
|
|
| Stephen T. Wills, CPA, MST |
|
|
| Executive Vice President, Chief Financial Officer and Chief Operating Officer |
|
3 |
EXHIBIT INDEX
| ||
|
4 |